NEW YORK (TheStreet) -- CHANGE IN RATINGS
Amphenol (APH) downgraded at BofA/Merrill to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $65 price target.
Berkshire Hathaway (A shares) (BRK.A) downgraded to hold at TheStreet Ratings.
Berkshire Hathaway (B shares) (BRK.B) downgraded to hold at TheStreet Ratings.Freescale Semi (FSL) rated new Neutral at UBS. $11.75 price target. Limited near term catalysts as turnaround in progress. Globus Medical (GMED) rated new Buy at Goldman. $18 price target. Company can deliver 13% annual sales growth and is reasonably valued. Globus Medical rated new Outperform at Oppenheimer. $18 price target. Company is growing faster than its peers and expanding internationally. GlaxoSmithKline (GSK) downgraded at UBS to Neutral from Buy, UBS said. $48.18 price target. Valuation, earnings visibility limit potential for further upside. KLA-Tencor (KLAC) downgraded at Deutsche from Hold to Sell, Deutsche Bank said. $44 price target. Company is leveraged to lower foundry spending. Pioneer Southwest (PSE) downgraded at UBS to Sell from Neutral, UBS said. $24 price target. Limited hedge book relative to peers.
STOCK COMMENTS / EPS CHANGESGilead (GILD) estimates, target increased at Jefferies. GILD estimates were raised through 2013, Jefferies said. Stribild quad pill was approved with the FDA and the company announced higher pricing. Hold rating and new $55 price target. Ingersoll-Rand (IR) target raised at UBS to $54, UBS said. Several potential catalysts including improving HVAC business conditions. Buy rating. M&T Bank (MTB) numbers boosted at Credit Suisse. Shares of MTB now seen reaching $102, according to Credit Suisse. Estimates also upped, as the HCBK acquisition should add to earnings. Neutral rating. PVH (PVH) estimates, target raised at Brean. Shares of PVH now seen reaching $115, according to Brean Murray. Estimates also increased, as the company is seeing better growth across the board. Buy rating. Rackspace (RAX) target boosted at JMP. Shares of RAX now seen reaching $65, according to JMP Securities. Company can continue to grow through its potential inclusion in the OpenStack Foundation. Outperform rating. VMWare (VMW) target raised at ThinkEquity to $105. Company can create a true enterprise datacenter destination. Buy rating. >To submit a news tip, email: email@example.com.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV